BIOCITECH, France - November 15 2007 - Cellectis SA, the rational genome engineering company specializing in the production of meganuclease recombination systems and in meganuclease engineering, today announced the delivery of a meganuclease targeting the RAG1 gene to Professor Luigi Notarangelo's research group at the Children’s Hospital Boston (USA).
